Jose Mourinho finally takes charge of Chelsea’s think-tank and starts signing his notable players. Germany international forward, Andre Schurrle, who has long been a favorite for the London club, is finally a man in the Blues. Notably, Chelsea’s earlier attempt to sign him could not materialize for some reasons but now new manager tries his best and used his negotiation skills to lure Bayer Leverkusen with a £18m paycheck which is much more than 22-year old forward had earlier demanded. The promising striker has a decent track record this season and scored 11 goals in 34 league games played for his German club Bayer Leverkusen. Moreover, with a third place in the league, Leverkusen has automatically qualified for the Championship league in Bundesliga. Actually, Schurrle had some talks with Chelsea last summer too but could not finalize the deal which he later regretted. For now, he will have to go through a medical test and probably some discussions for personal terms and then he can … [Read more...]
Bayer to offer Boudewijn Zenden Pay-Per-Play Deal
German football club: Bayer Leverkusen is taking note of an option where they can offer Dutch footballer: Boudewijn Zenden a unique pay per play deal where the player will get handsome remuneration for each of his match appearance. Reportedly, the said consideration was due for a long time coz the footballer is a free agent since last one year. The German club is looking for a solution to strengthen their midfield by signing Zenden as he is a senior attacking midfielder and currently aged around 36 years. Apparently, Zenden has already refused Sunderland’s offer to go with them last season, and he has since not signed up with any other club or team. Moreover, as his age is taking him to a retirement, he is continuously trying to keep himself fit and available for anyone who wants him to sign, hence Bayer’s offer looks very realistic and possible. Many believe that he may soon find a club before his retirement, so he is quite optimistic with pay per deal contract with Bayer in coming … [Read more...]